Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic acid for prevention of brain oxidative stress injury during sevoflurane anesthesia in hepatectomy
ChiCTR2300077321Phase 4Completed
- Sponsor
- Xuzhou Central Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alpha-lipoic acid in Anesthetic neurotoxicity (ANT) and Brain oxidative stress injury (2 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: 8-hydroxy-2'-deoxyguanosine. Started Nov 2023; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
Anesthetic neurotoxicity (ANT)Brain oxidative stress injury
Beyond the preview
Go deeper on ChiCTR2300077321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077321.